Capstone Therapeutics (CAPS) Earnings
|
Expand Research on CAPS
| Next EPS Date | 8/13/26 | EPS Growth Rate | +207.7% |
|---|---|---|---|
| Average EPS % Beat Rate | -133.3% | Revenue Growth Rate | +68.2% |
| Average % Move 1-Wk after EPS | -2.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/13/26  |
Q226 | N/A | $0.14 | N/A | N/A | $21.61M | N/A | N/A | N/A | ||
| 4/7/26 |
Q126 | N/A | -$0.13 | N/A | N/A | $11.34M | N/A | N/A | N/A | ||
| 5/20/26 |
Q126 | N/A | -$0.19 | N/A | $12.6M | $10.5M | N/A | N/A | N/A | ||
| 11/11/25 |
Q325 | N/A | $0.12 | N/A | N/A | $15.57M | N/A | N/A | N/A | ||
| 8/19/25 |
Q325 | N/A | $0.03 | N/A | N/A | $15.05M | N/A | N/A | N/A | ||
| 8/25/25 |
Q325 | N/A | $0.03 | N/A | N/A | $15.05M | N/A | N/A | N/A | ||
| 11/10/25 |
Q325 | N/A | $0.12 | N/A | N/A | $15.57M | N/A | N/A | N/A | ||
| 11/12/25 |
Q325 | N/A | $0.12 | N/A | N/A | $15.57M | N/A | N/A | N/A |
